Search results
Biomea Fusion Crashes 67% After FDA Puts Diabetes Treatment Studies On Hold
Investor's Business Daily· 46 minutes agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA...
Diabetes biotech stock tanks as FDA imposes full clinical hold
FierceBiotech· 3 hours agodiabetes program over liver toxicity concerns. In preclinical tests, the molecule improved beta cell...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 4 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...
Commonly Used Meds Tied to Lower Risk for Aneurysm Rupture
Medscape· 10 hours agoCommonly prescribed drugs are associated with lower risk for aneurysmal subarachnoid hemorrhage....
The disproportionate toll that COVID-19 took on people with diabetes continues today
Medical Xpress· 22 hours agoAt the start of the pandemic, many people living with diabetes were wondering what COVID-19 meant...
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe double-blind, placebo-controlled COVALENT-112 trial is designed to assess BMF-219 in 150 adults...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 1 day agoHowever, another drug designed to assist with type 2 diabetes treatment, metformin, had a 13-year...
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 2 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 3 hours ago(NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows the...
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 3 hours agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...